Abstract
Purpose
To assess the mid-term results of MR-guided percutaneous cryoablation for small hepatocellular carcinoma (HCC).
Methods
Using an argon-based cryoablation system, MR-guided percutaneous cryoablation was performed. The number of tumors was three or fewer. The maximum diameter of tumors was less than 5 cm when solitary and no more than 3 cm when multiple. The Kaplan–Meier method was used to calculate the survival of patients.
Results
Among 15 patients, 16 tumors were treated. The maximum tumor diameter ranged from 1.2 to 4.5 cm, with a mean of 2.5 ± 0.8 cm (mean ± standard deviation). The volume of iceballs measured on MR-images was greater than that of the tumors in all cases. The follow-up period ranged from 10 to 52 months, with a mean of 36.6 ± 12.1 months. One-year and 3-year overall survival were 93.8 and 79.3%, respectively. The complete ablation rate was 80.8% at 3 years. Immediate complications were pneumothorax, hemothorax, and pleural effusion. An ablation zone was not absorbed and content exuded from a scar of the probe tract 4 months after cryoablation in one patient.
Conclusion
MR-guided percutaneous cryoablation appears to be a feasible modality and potentially good option for the treatment of small HCC.
Similar content being viewed by others
References
Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171–86.
Onik G, Cooper C, Goldberg HI, Moss AA, Rubinsky B, Christianson M. Ultrasonic characteristics of frozen liver. Cryobiology. 1984;21:321–8.
Isoda H. Sequential MRI and CT in cryosurgery—an experimental study of rat. Nippon Igaku Hoshasen Gakkai Zasshi. 1989;49(12):1499–508.
Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology. 2000;217(3):657–64.
Zhou X, Tang Z. Cryotherapy for primary liver cancer. Semin Surg Oncol. 1998;14:171–4.
Dohi M, Harada J, Mogami T, Fukuda K, Toyama Y, Kashiwagi H. MR-guided percutaneous cryotherapy of malignant liver tumor under horizontal-magnetic open system: initial experience. J Hepatobiliary Pancreat Surg. 2003;10(5):360–5.
National Cancer Institute. Cancer therapy evaluation program: common toxicity evaluation manual, version 2.0, 1999.
Jansen MC, van Hillegersberg R, Chamuleau RA, et al. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol. 2005;31(4):331–47.
Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137(12):1332–9.
Helling TS. Realistic expectations for cryoablation of liver tumors. J Hepatobiliary Pancreat Surg. 2000;7(5):510–5.
Seifert JK, Junquinger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb. 1998;43(3):141–54.
Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 2008;47(1):82–9.
Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97(5):1253–62.
Rewcastle JC, Sandison GA, Muldrew K, et al. A model for the time dependent three-dimensional thermal distribution within iceballs surrounding multiple cryoprobes. Med Phys. 2001;28(6):1125–37.
Saliken JC, Cohen J, Miller R, et al. Laboratory evaluation of ice formation around a 3-mm accuprobe. Cryobiology. 1995;32(3):285–95.
Onik G. Cryosurgery. Hematology. 1996;23:1–24.
Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function. Ann Surg. 2002;235(3):373–82.
Zavaglia C, Corso R, Rampoldi A, et al. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure? Eur J Gastroenterol Hepatol. 2008;20(3):196–201.
Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38(10):977–81.
Sarantou T, Bilchik A, Ramming KP. Complications of hepatic cryosurgery. Semin Surg Oncol. 1998;14(2):156–62.
Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.
Klotz HP, Flury R, Shönenberger A, Debatin JF, Uhlschmid G, Largiadér F. Experimental cryosurgery of the liver under magnetic resonance guidance. Comput Aided Surg. 1997;2:340–5.
Tacke J, Adam G, Haage P, Sellhaus B, Großkortenhaus S, Günther RW. MR-guided percutaneous cryotherapy of the liver: in vivo evaluation with histologic correlation in an animal model. J Magn Reson. 2001;13:50–6.
Acknowledgment
This study is supported by HITACHI Medical Corporation.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shimizu, T., Sakuhara, Y., Abo, D. et al. Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 16, 816–823 (2009). https://doi.org/10.1007/s00534-009-0124-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00534-009-0124-4